Pharmacy News

May 2016
WSI recently published a new medical policy, Chronic Opioid Therapy. This policy is a result of the 2015 North Dakota Legislative Assembly amending North Dakota Century Code (N.D.C.C.) § 65-05-39 to address chronic opioid therapy.
July 2015
On August 1, 2015, WSI will utilize US Script®, to provide the same point-of-sale transactions currently in place with tmesys®.
January 2015
Effective February 1, 2015, WSI will require prior authorization of long-acting opioid medication.
October 2013
On November 1, 2013, WSI will utilize PMSI® d.b.a. tmesys®, to provide the same point-of-sale transactions currently in place with US Script®.
May 2013
On April 17, 2013 Oxycontin was scheduled to go off the patent protection and become available for the generic marketplace.